PCM
BIVV

Parsons Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Parsons Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,882
Closed -$856K – 369
2017
Q4 		$856K Hold
15,882
– – 0.1% 192
2017
Q3 		$906K Buy
15,882
+3,125
+24% +$183K 0.11% 185
2017
Q2 		$768K Sell
12,757
-64
-0.5% -$3.64K 0.09% 200
2017
Q1 		$698K Buy
+12,821
New +$632K 0.09% 199

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Parsons Capital Management's BIVV Position: Q1 2018 in Review

Parsons Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 15,882 shares — an estimated $856K sold.

Parsons Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $906K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Parsons Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Parsons Capital Management sold 15,882 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $856K.
  • Parsons Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Parsons Capital Management's Bioverativ Inc. Common Stock position peaked at $906K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Parsons Capital Management's 13F filing for Q1 2018, filed 7 May 2018.